Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differential growth patterns in SCID mice of patient-derived chronic myelogenous leukemias.

Bone marrow transplantation - 1 Aug 1998

McGuirk J, Yan Y, Childs B, Fernandez J, Barnett L, Jagiello C, Collins N, O'Reilly R J

Abstract excerpt

The development of an in vivo model for the study of CML would be of significant importance in studying its biological behavior and developing novel therapeutic strategies. We examined the ability of human leukemic cells derived from patients in either chronic (CP), accelerated (AP) or blast phase (BP) CML to grow and disseminate in CB17-SCID mice by subcutaneous (s.c.) inoculation without conditioning treatment...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Child
Share to Disease Models, Animal

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Flow Cytometry

Share to In Situ Hybridization, Fluorescence

Share to Neoplasm Transplantation

Share to Phenotype

Source

Identifiers

PMID: 9722072
DOI: 10.1038/sj.bmt.1701343

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Differential growth patterns in SCID mice of patient-derived chronic myelogenous leukemias.PMID 9722072Read ↗

Graft-versus-Leukemia (GVL) against Mouse Blast-Crisis Chronic Myelogenous Leukemia (BC-CML) and Chronic-Phase Chronic Myelogenous Leukemia (CP-CML): Shared Mechanisms of T Cell Killing, but Programmed Death Ligands Render CP-CML and Not BC-CML GVL ResistantSemantic proximity Read ↗

Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease.Semantic proximity Read ↗

Immature NK cells suppress dendritic cell functions during the development of leukemia in a mouse model.Semantic proximity Read ↗

Biological properties and growth in SCID mice of a new myelogenous leukemia cell line (KBM-5) derived from chronic myelogenous leukemia cells in the blastic phase.Semantic proximity Read ↗

Tumor dormancy resulting from subcutaneous injection to SCID mice with cultured nasopharyngeal carcinoma cells is mediated via IFN-γ induction of a highly differentiated phenotype.Semantic proximity Read ↗

Differential kinetics of engraftment and induction of CD10 on human pre-B leukemia cell lines in immune deficient scid mice.Semantic proximity Read ↗

X-linked dominant growth suppression of transplanted tumors in C57BL/6J-scid mice.Semantic proximity Read ↗

Cross-protective murine graft-versus-leukemia responses to phenotypically distinct myeloid leukemia lines.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.